ArticleCell death & disease2025

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Ersilia Varone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.